Breaking News Instant updates and real-time market news.

ABT

Abbott

$79.81

0.2 (0.25%)

, TNDM

TNDM

08:04
10/15/19
10/15
08:04
10/15/19
08:04

Abbott, Tandem Diabetes to partner on integrated diabetes solutions

Abbott (ABT) and Tandem Diabetes Care (TNDM) announced that they intend to develop and commercialize integrated diabetes solutions that combine Abbott's world-leading glucose sensing technology with Tandem's innovative insulin delivery systems to provide more options for people to manage their diabetes.

ABT

Abbott

$79.81

0.2 (0.25%)

TNDM

TNDM

  • 16

    Oct

  • 04

    Nov

  • 14

    Nov

ABT Abbott
$79.81

0.2 (0.25%)

07/18/19
BMOC
07/18/19
NO CHANGE
Target $94
BMOC
Outperform
Abbott price target raised to $94 from $87 at BMO Capital
BMO Capital analyst Joanne Wuensch raised her price target on Abbott to $94 and kept her Outperform rating after its Q2 earnings beat and a raise in FY19 guidance, saying the company is among a "handful" of medtech names that deliver above-market revenue and double-digit earnings growth along with operating leverage. The analyst notes that following its AbbVie spinoff and acquisition of St. Jude Medical and Alere, Abbott's growth drivers of Alinity, Libre and MitraClip are "humming along" - a trend she expects to continue.
07/18/19
COWN
07/18/19
NO CHANGE
Target $95
COWN
Outperform
Abbott price target raised to $95 from $86 at Cowen
Cowen analyst Joshua Jennings raised his price target on Abbott to $95 from $86 following Q2 earnings. The analyst said the quarter's highlight was the organic sales growth of 7.5% which was above its target of 7.0%, reflecting continued strength for Libre, MitraClip, and Alinity. He noted management raised it guidance for organic sales growth and earnings and he believes the company can continue to post above consensus results in the second half of the year. Jennings reiterated his Outperform rating on Abbott shares.
07/18/19
JEFF
07/18/19
NO CHANGE
Target $98
JEFF
Buy
Abbott price target raised to $98 from $80 at Jefferies
Jefferies analyst Raj Denhoy raised his price target for Abbott Laboratories to $98 from $80 saying the company's growth story is "still going strong" following its Q2 results. The quarter is more proof that the pharma exit and medtech "double-down" was right move, Denhoy tells investors in a research note. Despite Abbott's "strong" current momentum, each product cycle is still in early innings, adds the analyst. He keeps a Buy rating on the shares.
09/23/19
PIPR
09/23/19
NO CHANGE
Target $182
PIPR
Overweight
DexCom remains a 'must own' stock for investors, says Piper Jaffray
After hosting meetings with management, Piper Jaffray analyst JP McKim believes DexCom (DXCM) remains "a must own for investors." First off, the analyst does not believe the company was "walking down" numbers at a recent investor conference. Continuous glucose monitoring demand remains "robust" and importantly, G7 is only 12-15 months away, McKim tells investors in a research note. The analyst also left the meetings "with a lot more bullishness" on the hospital market as well as the non-intensive Type 2 market, where he believes DexCom's sensor technology will have an impact. McKim does expect share volatility around the near-term approval of Abbott's (ABT) Libre 2.0 with integrated continuous glucose monitoring, but he believes the impact DexCom "will be short lived in nature." McKim keeps an Overweight rating on the shares with a $182 price target. The stock closed Friday down 59c to $154.40.
TNDM TNDM

09/23/19
PIPR
09/23/19
NO CHANGE
PIPR
Overweight
Insulet ACE designation a 'nice win,' says Piper Jaffray
Insulet's (PODD) announcement this morning of an Alternate Controller Enabled designation from the FDA for OmniPod DASH is a "nice win" for the company, Piper Jaffray analyst JP McKim tells investors in a research note. Insulet is the second pump company to receive this designation as Tandem Diabetes (TNDM) has it as well, adds the analyst, who keeps an Overweight rating on Insulet shares.
09/27/19
PIPR
09/27/19
NO CHANGE
PIPR
Piper says insulin pump survey most positive for Insulet
Piper Jaffray analyst JP McKim conducted an insulin delivery survey in August and found that pump penetration is going "much higher" both in type 1s and in type 2s. The growth in the type 2 market is underappreciated by investors and will largely benefit Insulet (PODD) today given the pharmacy channel increases that access, McKim tells investors in a research note. Further, survey indicated that Medtronic (MDT) is expected to lose between 1,100-1,300 basis points of market share with Tandem Diabetes (TNDM) being the greatest beneficiary with the biggest uptick forecast in 2020, says the analyst. McKim views the insulin pump survey as most positive for Insulet.
10/04/19
UBSW
10/04/19
UPGRADE
Target $75
UBSW
Buy
UBS upgrades Tandem Diabetes to Buy with 33% upside potential
UBS analyst Matthew Taylor upgraded Tandem Diabetes Care to Buy from Neutral with an unchanged price target of $75. The stock closed Thursday up $1.53 to $56.58. The analyst says that while he understands concerns about slowing growth on tough comps, he sees "several sources of growth" that should allow Tandem to deliver upside to consensus in 2020 and beyond. The stock offers 33% upside from current levels and a favorable risk/reward skew, Taylor tells investors in a research note. While Tandem will derive less revenue from Animas patients next year, the gap can be more than filled by pump market growth that is accelerating, market share gains of new patients, and the company's "underpenetrated" growth outside the U.S., contends the analyst.
10/04/19
10/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Snap (SNAP) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Brian Nowak saying he acknowledges that in the year-to-date he has underestimated Snap's stronger execution and ability to drive growth. 2. Charter (CHTR) upgraded to Overweight from Sector Weight at KeyBanc with analyst Brandon Nispel saying he believes Charter remains well positioned to benefit from increased penetration rates in broadband, higher download speed take rates to drive broadband prices higher, and an overall mix shift to higher-margin "Growth Business." 3. Boston Beer (SAM) upgraded to Neutral from Sell at UBS with analyst Sean King saying he has greater confidence in the company's fiscal 2020 sales growth story "flowing through to earnings growth." 4. Hub Group (HUBG) upgraded to Overweight from Neutral at JPMorgan. 5. Tandem Diabetes (TNDM) upgraded to Buy at UBS with 33% upside potential with analyst Matthew Taylor saying while he understands concerns about slowing growth on tough comps, he sees "several sources of growth" that should allow Tandem to deliver upside to consensus in 2020 and beyond. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

RH

RH

$174.48

-0.18 (-0.10%)

20:56
11/12/19
11/12
20:56
11/12/19
20:56
Initiation
RH initiated  »

RH initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVH

PVH Corp.

$96.91

0.14 (0.14%)

20:53
11/12/19
11/12
20:53
11/12/19
20:53
Initiation
PVH Corp. initiated  »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

JWN

Nordstrom

$36.90

-0.52 (-1.39%)

20:51
11/12/19
11/12
20:51
11/12/19
20:51
Initiation
Nordstrom initiated  »

Nordstrom initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NKE

Nike

$89.51

-0.52 (-0.58%)

20:46
11/12/19
11/12
20:46
11/12/19
20:46
Initiation
Nike initiated  »

Nike initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EYE

National Vision

$27.03

0.24 (0.90%)

20:43
11/12/19
11/12
20:43
11/12/19
20:43
Initiation
National Vision initiated  »

National Vision initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$17.53

0.02 (0.11%)

20:40
11/12/19
11/12
20:40
11/12/19
20:40
Initiation
L Brands initiated  »

L Brands initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BABA

Alibaba

$186.97

0.26 (0.14%)

20:25
11/12/19
11/12
20:25
11/12/19
20:25
Periodicals
Alibaba gets approval to sell shares in Hong Kong, SCMP reports »

Alibaba has received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ENR

Energizer

$42.01

-1.1 (-2.55%)

, SPB

Spectrum Brands

$51.19

-0.76 (-1.46%)

20:25
11/12/19
11/12
20:25
11/12/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ENR

Energizer

$42.01

-1.1 (-2.55%)

SPB

Spectrum Brands

$51.19

-0.76 (-1.46%)

SSYS

Stratasys

$20.74

0.04 (0.19%)

FVRR

Fiverr

$21.56

-0.47 (-2.13%)

MTOR

Meritor

$23.44

-0.25 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 21

    Nov

  • 09

    Dec

  • 12

    Dec

DDOG

Datadog

$34.40

0.89 (2.66%)

20:02
11/12/19
11/12
20:02
11/12/19
20:02
Hot Stocks
Datadog establishes Japanese subsidiary »

Datadog announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 19

    Nov

NKE

Nike

$89.51

-0.52 (-0.58%)

, AMZN

Amazon.com

$1,778.33

6.63 (0.37%)

19:40
11/12/19
11/12
19:40
11/12/19
19:40
Periodicals
Nike says to end retail pilot project w/ Amazon.com but continue AWS partnership 

Report from Bloomberg.

NKE

Nike

$89.51

-0.52 (-0.58%)

AMZN

Amazon.com

$1,778.33

6.63 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

HPE

HP Enterprise

$17.34

-0.11 (-0.63%)

, FJTSY

Fujitsu

$0.00

(0.00%)

19:34
11/12/19
11/12
19:34
11/12/19
19:34
Hot Stocks
HP Enterprise's Cray to partner with Fujitsu on 'supercomputer' technology »

Cray, a Hewlett Packard…

HPE

HP Enterprise

$17.34

-0.11 (-0.63%)

FJTSY

Fujitsu

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

IMAX

Imax

$21.26

-0.62 (-2.83%)

19:23
11/12/19
11/12
19:23
11/12/19
19:23
Hot Stocks
Imax names Edwin Tan as CEO of Imax China »

IMAX China announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$308.96

0.57 (0.18%)

19:21
11/12/19
11/12
19:21
11/12/19
19:21
Periodicals
Tariffs on China imports become stumbling block to trade pact, WSJ says »

Tariffs are emerging as…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$308.96

0.57 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$0.67

-0.138 (-17.08%)

19:19
11/12/19
11/12
19:19
11/12/19
19:19
Hot Stocks
Chesapeake CEO says 'strongly' believes in current capital program »

November 12, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,298.77

0.01 (0.00%)

, GOOGL

Alphabet Class A

$1,297.18

-0.8 (-0.06%)

19:17
11/12/19
11/12
19:17
11/12/19
19:17
Periodicals
HHS opens federal probe into Google's 'Project Nightingale,' WSJ reports »

The Office for Civil…

GOOG

Alphabet

$1,298.77

0.01 (0.00%)

GOOGL

Alphabet Class A

$1,297.18

-0.8 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$83.30

1.27 (1.55%)

19:10
11/12/19
11/12
19:10
11/12/19
19:10
Hot Stocks
Starbucks unveils 35,000 sq foot reserve roastery in Chicago. »

Starbucks unveiled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$137.42

0.37 (0.27%)

19:00
11/12/19
11/12
19:00
11/12/19
19:00
Hot Stocks
SPDR Gold Shares holdings fall to 897.09MT from 901.19MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTE

PolarityTE

$2.89

-0.41 (-12.42%)

18:57
11/12/19
11/12
18:57
11/12/19
18:57
Recommendations
PolarityTE analyst commentary  »

PolarityTE price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

DK

Delek US

$38.45

-0.06 (-0.16%)

18:51
11/12/19
11/12
18:51
11/12/19
18:51
Hot Stocks
Delek US CFO sells 50K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDLX

Cardlytics

$39.85

0.17 (0.43%)

, TWOU

2U

$22.58

0.77 (3.53%)

18:44
11/12/19
11/12
18:44
11/12/19
18:44
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

CDLX

Cardlytics

$39.85

0.17 (0.43%)

TWOU

2U

$22.58

0.77 (3.53%)

OPNT

Opiant Pharmaceuticals

$15.95

0.18 (1.14%)

DDOG

Datadog

$34.40

0.89 (2.66%)

PTE

PolarityTE

$2.89

-0.41 (-12.42%)

ADPT

Adaptive Biotechnologies

$28.35

0.01 (0.04%)

ADT

ADT Inc.

$7.70

-0.02 (-0.26%)

BDSI

BioDelivery Sciences

$5.86

0.02 (0.34%)

AQMS

Aqua Metals

$1.45

-0.065 (-4.29%)

YY

YY

$65.12

-0.28 (-0.43%)

HUYA

Huya

$24.28

-1.05 (-4.15%)

RUN

Sunrun

$14.49

0.08 (0.56%)

VRAY

ViewRay

$2.48

-0.145 (-5.53%)

DZSI

Dasan Zhone

$8.34

0.5 (6.38%)

HIIQ

Health Insurance Innovations

$23.27

-1.71 (-6.85%)

CBPX

Continental Building

$35.76

3.73 (11.65%)

KNSL

Kinsale Capital Group

$88.98

1.78 (2.04%)

BOXL

Boxlight

$1.94

0.19 (10.86%)

SSTI

ShotSpotter

$20.36

(0.00%)

TVTY

Tivity Health

$18.56

0.145 (0.79%)

GEVO

Gevo

$2.57

0.065 (2.59%)

CSIQ

Canadian Solar

$17.51

0.65 (3.86%)

SDC

SmileDirectClub

$11.02

-0.83 (-7.00%)

SWKS

Skyworks

$101.59

1.22 (1.22%)

VREX

Varex Imaging

$32.68

0.1 (0.31%)

TLRY

Tilray

$21.57

-0.4 (-1.82%)

NXTC

NextCure

$37.41

-1.45 (-3.73%)

HALO

Halozyme

$16.77

0.18 (1.09%)

CYBR

CyberArk

$115.30

1.45 (1.27%)

I

Intelsat

$20.39

-2.845 (-12.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 03

    Dec

  • 04

    Dec

  • 04

    Dec

  • 05

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 17

    Dec

  • 15

    Nov

MU

Micron

$46.89

0.64 (1.38%)

18:44
11/12/19
11/12
18:44
11/12/19
18:44
Hot Stocks
Micron CEO: We are focused on new product introductions »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

WSFS

WSFS Financial

$44.57

0.12 (0.27%)

18:34
11/12/19
11/12
18:34
11/12/19
18:34
Hot Stocks
WSFS Financial names Rodger Levenson chairman of the board »

WSFS Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

REAL

RealReal

$18.30

0.08 (0.44%)

18:34
11/12/19
11/12
18:34
11/12/19
18:34
Hot Stocks
RealReal CEO: Our brand is to keep fakes off the market »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

  • 09

    Dec

USB

U.S. Bancorp

$58.49

-0.16 (-0.27%)

18:31
11/12/19
11/12
18:31
11/12/19
18:31
Hot Stocks
U.S. Bancorp receives Fed board of governors approval for capital distribution »

U.S. Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 15

    Jan

IKTSY

Intertek

$0.00

(0.00%)

18:29
11/12/19
11/12
18:29
11/12/19
18:29
Upgrade
Intertek rating change at Goldman Sachs »

Intertek upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.